http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10236980-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bba0a34651fd8cd73cf83e6a9effe12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 1997-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede47ea5d3dc8381d330a03c25b5fda8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1425749cf37146f025cc5371cad13d3f |
| publicationDate | 1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10236980-A |
| titleOfInvention | Rectal formulation containing serotonin receptor antagonist |
| abstract | (57) [Problem] To provide a rectal administration preparation capable of efficiently absorbing a serotonin receptor antagonist from the intestinal mucosa and having low irritation to the intestinal mucosa. SOLUTION: A rectal administration preparation containing a serotonin receptor antagonist, comprising a serotonin receptor antagonist as an active ingredient and a glycerin ester of a saturated fatty acid or unsaturated fatty acid having 8 to 18 carbon atoms as a base component. . The glycerin ester preferably has a hydroxyl value of 50 to 90. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066913-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006006595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014012725-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019235308-A1 |
| priorityDate | 1997-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.